MX2011002065A - Composicion farmaceutica a base de progesterona micronizada y sus usos. - Google Patents

Composicion farmaceutica a base de progesterona micronizada y sus usos.

Info

Publication number
MX2011002065A
MX2011002065A MX2011002065A MX2011002065A MX2011002065A MX 2011002065 A MX2011002065 A MX 2011002065A MX 2011002065 A MX2011002065 A MX 2011002065A MX 2011002065 A MX2011002065 A MX 2011002065A MX 2011002065 A MX2011002065 A MX 2011002065A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
micronised progesterone
micronised
relates
progesterone pharmaceutical
Prior art date
Application number
MX2011002065A
Other languages
English (en)
Inventor
Jennifer Gicquel
Didier Terracol
Roland Samoyeau
Original Assignee
Effik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Effik filed Critical Effik
Publication of MX2011002065A publication Critical patent/MX2011002065A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica que contiene progesterona micronizada y al menos un aceite denominado aceite de cártamo de tipo II. Esta también se refiere a los medicamentos que comprenden la composición farmacéutica. La invención también se refiere a los usos médicos de esta composición farmacéutica.
MX2011002065A 2009-06-29 2009-12-09 Composicion farmaceutica a base de progesterona micronizada y sus usos. MX2011002065A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0954420A FR2947178B1 (fr) 2009-06-29 2009-06-29 Composition pharmaceutique a base de progesterone micronisee et ses utilisations
PCT/FR2009/052461 WO2011001039A1 (fr) 2009-06-29 2009-12-09 Composition pharmaceutique a base de progesterone micronisee et ses utilisations

Publications (1)

Publication Number Publication Date
MX2011002065A true MX2011002065A (es) 2011-09-01

Family

ID=41664573

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011002065A MX2011002065A (es) 2009-06-29 2009-12-09 Composicion farmaceutica a base de progesterona micronizada y sus usos.

Country Status (12)

Country Link
US (1) US20100330168A1 (es)
EP (1) EP2269592B1 (es)
KR (1) KR20120037363A (es)
BR (1) BRPI0911019A2 (es)
CA (1) CA2698513A1 (es)
CL (1) CL2011000214A1 (es)
FR (1) FR2947178B1 (es)
MA (1) MA32548B1 (es)
MX (1) MX2011002065A (es)
RU (1) RU2011103136A (es)
WO (1) WO2011001039A1 (es)
ZA (1) ZA201100605B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
LT2782584T (lt) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
AU2015296609A1 (en) 2014-07-29 2016-12-22 Therapeuticsmd, Inc. Transdermal cream
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
FR3053252B1 (fr) * 2016-06-29 2020-04-24 Laboratoires Carilene Produit, ou agent actif, ou composition pour le soin des seins en periode pre-mensuelle ou menstruelle ou pour le soin de la symptomatologie des mastodynies
EP3395332A1 (en) 2017-04-28 2018-10-31 Chemo Research, S.L. Hormone softgel capsules and a process for the preparation thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4963540A (en) * 1986-04-16 1990-10-16 Maxson Wayne S Method for treatment of premenstrual syndrome
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
DE3874320T2 (de) * 1987-10-05 1992-12-17 Pharmagyn Inc Tablette zur behandlung bei progesteronmangel.
US5093265A (en) * 1987-12-16 1992-03-03 Genesis Systems Corporation Method for detecting of premenstrual syndrome
CA2059555A1 (en) * 1990-06-01 1991-12-02 Merrick L. Shively Self-emulsifying glasses
US5912416A (en) * 1997-08-05 1999-06-15 California Oils Corporation Safflower products with very high levels of unsaturated fatty acids
FR2832065B1 (fr) * 2001-11-13 2004-11-05 Besins Int Belgique Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations
MY142989A (en) * 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
ATE543489T1 (de) * 2005-05-26 2012-02-15 Teva Womens Health Inc Orale dosierformen mit progesteron und verwendungs- und herstellungsverfahren dafür
EP2016833A1 (de) * 2007-07-17 2009-01-21 Cognis IP Management GmbH Emulsion

Also Published As

Publication number Publication date
KR20120037363A (ko) 2012-04-19
FR2947178B1 (fr) 2012-07-06
ZA201100605B (en) 2012-04-25
MA32548B1 (fr) 2011-08-01
RU2011103136A (ru) 2013-08-10
EP2269592B1 (fr) 2013-08-07
CA2698513A1 (fr) 2010-12-29
EP2269592A1 (fr) 2011-01-05
CL2011000214A1 (es) 2011-05-27
BRPI0911019A2 (pt) 2016-07-19
FR2947178A1 (fr) 2010-12-31
WO2011001039A1 (fr) 2011-01-06
US20100330168A1 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
MX2011002065A (es) Composicion farmaceutica a base de progesterona micronizada y sus usos.
PH12016500216A1 (en) Stable pharmaceutical composition and methods of using same
MX2012003555A (es) Composicion farmaceutica que comprende acido graso omega-3 y derivado hidroxi de una estatina y metodos para usar la misma.
MY158504A (en) Fatty acid niacin conjugates and their uses
MX2012012837A (es) Composiciones farmaceuticas y metodos para su elaboracion.
CY1116695T1 (el) Συνθεση περιεχοντας υπερ-μικρονοποιημενο παλμιτοϋλ-αιθανολαμιδιο
EA201690107A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
TN2011000471A1 (en) Pharmaceutical composition presenting anti-inflammatory properties
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
TN2012000126A1 (en) Polycyclic compounds as lysophosphatidic acid receptor antagonists
IN2012DN01233A (es)
UA106634C2 (uk) Тверда фармацевтична дозована форма
IN2015DN00185A (es)
MX2012007806A (es) Composiciones farmaceuticas para administracion oral de peptidos de insulina.
MX2011012122A (es) Derivados de tiofeno.
MX2010002815A (es) Composiciones farmaceuticas que contienen toxoides a y b de clostridium difficile.
MX2019000547A (es) Formulaciones de adamts13 liquidas y liofilizadas, estabilizadas.
WO2011141685A3 (fr) Compositions nasales a visee systemique a base de cocoyl proline ou d'au moins un de ses constituants
MY164842A (en) Isoxazolidine derivatives
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
MX367926B (es) Composicion farmaceutica para liberacion sostenida de lanreotida.
MX2012000954A (es) Composicion far,aceutica topica que incuye la rel-n-[6-[(2r,6s)-2,6-dimetil-4-morfolinil]-3-piridinil]-2-metil- 4'-(trifluoro-metoxi)-[1,1'-bifenil]-3-carboxamida.
MA34580B1 (fr) Valsartan hautement cristallin
EP2611799A4 (en) PHARMACEUTICAL COMPOSITIONS OF LINEZOLID
IN2015DN02296A (es)